Cargando…

Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment

Significance: Photodynamic therapy (PDT) involves complex light-drug-pathophysiology interactions that can be affected by multiple parameters and often leads to large variations in treatment outcome from patient to patient. Direct PDT dosimetry technologies have been sought to optimize the control v...

Descripción completa

Detalles Bibliográficos
Autores principales: Moritz, Tobias J., Zhao, Youbo, Hinds, Michael F., Gunn, Jason R., Shell, Jennifer R., Pogue, Brian W., Davis, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Photo-Optical Instrumentation Engineers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068220/
https://www.ncbi.nlm.nih.gov/pubmed/32170859
http://dx.doi.org/10.1117/1.JBO.25.6.063810
_version_ 1783505530516406272
author Moritz, Tobias J.
Zhao, Youbo
Hinds, Michael F.
Gunn, Jason R.
Shell, Jennifer R.
Pogue, Brian W.
Davis, Steven J.
author_facet Moritz, Tobias J.
Zhao, Youbo
Hinds, Michael F.
Gunn, Jason R.
Shell, Jennifer R.
Pogue, Brian W.
Davis, Steven J.
author_sort Moritz, Tobias J.
collection PubMed
description Significance: Photodynamic therapy (PDT) involves complex light-drug-pathophysiology interactions that can be affected by multiple parameters and often leads to large variations in treatment outcome from patient to patient. Direct PDT dosimetry technologies have been sought to optimize the control variables (e.g., light dose, drug administration, tissue oxygenation, and patient conditioning) for best patient outcomes. In comparison, singlet oxygen ([Formula: see text]) dosimetry has been tested in various forms to provide an accurate and perhaps comprehensive prediction of the treatment efficacy. Aim: We discuss an advanced version of this approach provided by a noninvasive, continuous wave dosimeter that can measure near-infrared spectrally resolved luminescence of both photosensitizer (PS) and [Formula: see text] generated during PDT cancer treatment. Approach: This dosimetry technology uses an amplified, high quantum efficiency InGaAs detector with spectroscopic decomposition during the light treatment to continuously extract the maximum signal of [Formula: see text] phosphorescence while suppressing the strong PS luminescence background by spectrally fitting the data points across nine narrow band wavelengths. [Formula: see text] and PS luminescence signals were measured in vivo in FaDu xenograft tumors grown in mice during PDT treatment using Verteporfin as the PS and a continuous laser treatment at 690 nm wavelength. Results: A cohort of 19 mice was used and observations indicate that the tumor growth rate inhibition showed a stronger correlation with [Formula: see text] than with just the PS signal. Conclusions: These results suggest that [Formula: see text] measurement may be a more direct dosimeter of PDT damage, and it has potential value as a definitive diagnostic for PDT treatment, especially with spectral separation of the background luminescence and online estimation of the PS concentration.
format Online
Article
Text
id pubmed-7068220
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Society of Photo-Optical Instrumentation Engineers
record_format MEDLINE/PubMed
spelling pubmed-70682202020-03-18 Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment Moritz, Tobias J. Zhao, Youbo Hinds, Michael F. Gunn, Jason R. Shell, Jennifer R. Pogue, Brian W. Davis, Steven J. J Biomed Opt Special Section on Photodynamic Therapy Significance: Photodynamic therapy (PDT) involves complex light-drug-pathophysiology interactions that can be affected by multiple parameters and often leads to large variations in treatment outcome from patient to patient. Direct PDT dosimetry technologies have been sought to optimize the control variables (e.g., light dose, drug administration, tissue oxygenation, and patient conditioning) for best patient outcomes. In comparison, singlet oxygen ([Formula: see text]) dosimetry has been tested in various forms to provide an accurate and perhaps comprehensive prediction of the treatment efficacy. Aim: We discuss an advanced version of this approach provided by a noninvasive, continuous wave dosimeter that can measure near-infrared spectrally resolved luminescence of both photosensitizer (PS) and [Formula: see text] generated during PDT cancer treatment. Approach: This dosimetry technology uses an amplified, high quantum efficiency InGaAs detector with spectroscopic decomposition during the light treatment to continuously extract the maximum signal of [Formula: see text] phosphorescence while suppressing the strong PS luminescence background by spectrally fitting the data points across nine narrow band wavelengths. [Formula: see text] and PS luminescence signals were measured in vivo in FaDu xenograft tumors grown in mice during PDT treatment using Verteporfin as the PS and a continuous laser treatment at 690 nm wavelength. Results: A cohort of 19 mice was used and observations indicate that the tumor growth rate inhibition showed a stronger correlation with [Formula: see text] than with just the PS signal. Conclusions: These results suggest that [Formula: see text] measurement may be a more direct dosimeter of PDT damage, and it has potential value as a definitive diagnostic for PDT treatment, especially with spectral separation of the background luminescence and online estimation of the PS concentration. Society of Photo-Optical Instrumentation Engineers 2020-03-13 2020-06 /pmc/articles/PMC7068220/ /pubmed/32170859 http://dx.doi.org/10.1117/1.JBO.25.6.063810 Text en © 2020 The Authors https://creativecommons.org/licenses/by/4.0/ Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI.
spellingShingle Special Section on Photodynamic Therapy
Moritz, Tobias J.
Zhao, Youbo
Hinds, Michael F.
Gunn, Jason R.
Shell, Jennifer R.
Pogue, Brian W.
Davis, Steven J.
Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment
title Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment
title_full Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment
title_fullStr Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment
title_full_unstemmed Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment
title_short Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment
title_sort multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment
topic Special Section on Photodynamic Therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068220/
https://www.ncbi.nlm.nih.gov/pubmed/32170859
http://dx.doi.org/10.1117/1.JBO.25.6.063810
work_keys_str_mv AT moritztobiasj multispectralsingletoxygenandphotosensitizerluminescencedosimeterforcontinuousphotodynamictherapydoseassessmentduringtreatment
AT zhaoyoubo multispectralsingletoxygenandphotosensitizerluminescencedosimeterforcontinuousphotodynamictherapydoseassessmentduringtreatment
AT hindsmichaelf multispectralsingletoxygenandphotosensitizerluminescencedosimeterforcontinuousphotodynamictherapydoseassessmentduringtreatment
AT gunnjasonr multispectralsingletoxygenandphotosensitizerluminescencedosimeterforcontinuousphotodynamictherapydoseassessmentduringtreatment
AT shelljenniferr multispectralsingletoxygenandphotosensitizerluminescencedosimeterforcontinuousphotodynamictherapydoseassessmentduringtreatment
AT poguebrianw multispectralsingletoxygenandphotosensitizerluminescencedosimeterforcontinuousphotodynamictherapydoseassessmentduringtreatment
AT davisstevenj multispectralsingletoxygenandphotosensitizerluminescencedosimeterforcontinuousphotodynamictherapydoseassessmentduringtreatment